Apart from these studies, Venkataramani et al. (2010) reported β-amyloid precursor protein (APP) as the target of VPA, where its downregulation through HDAC inhibition decreased the proliferation of human pancreatic adenocarcinoma and colon cancer cells [30]. This evidence concerns the gene HDAC9 and pancreatic adenocarcinoma.